Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Alemtuzumab in multiple sclerosis: an update.
The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors.
Structural and Functional Abnormalities of the Neuromuscular Junction in the Trembler-J Homozygote Mouse Model of Congenital Hypomyelinating Neuropathy.
Differences in Body Composition Across Levels of Disability Among Ambulatory Patients Living With Multiple Sclerosis: 2569 Board #92 June 3, 9: 30 AM - 11: 00 AM.
Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report.
The expanded spectrum of neuromyelitis optica: evidences for a new definition.
Genomic Characterization of Japanese Macaque Rhadinovirus: A Novel Herpesvirus Isolated from a Nonhuman Primate with a Spontaneous Inflammatory Demyelinating Disease.
Validity of an Observation Method for Assessing Pain Behavior in Individuals With Multiple Sclerosis.
State vocational rehabilitation services and employment in multiple sclerosis.
Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.
Mutations in the PLEKHG5 gene is relevant with autosomal recessive intermediate Charcot-Marie-Tooth disease.
Gait and jogging parameters in people with minimally impaired multiple sclerosis.
A Friend in Need may not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases.
Changing face of multiple sclerosis in the United kingdom 1990-2010. An incidence and prevalence study.
Walking and cognition, but not symptoms, correlate with dual task cost of walking in multiple sclerosis.
Variability in the CIITA gene interacts with HLA in multiple sclerosis.
Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis.
Visual pathway neurodegeneration winged by mitochondrial dysfunction.
[Pegylated interferon beta 1a : A new therapy option for treatment of relapsing-remitting multiple sclerosis].
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.
Parallel changes in structural and functional measures of optic nerve myelination after optic neuritis.
Inhibition of Interferon regulatory factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Experiences of hospitalization in patients with multiple sclerosis: A qualitative study.
Statins in neurological disorders: An overview and update.
Visibility of lipid resonances in HR-MAS spectra of brain biopsies subject to spinning rate variation.
Pages
« first
‹ previous
…
436
437
438
439
440
441
442
443
444
…
next ›
last »